hyperimmune globulins market

Global Hyperimmune Globulins Market Analysis 2016-2020 and Forecast 2021-2026

  • Published Date: 2021-03-18
  • Report ID: 70565
  • Pages: 78
  • Format: prudent report format

Snapshot

Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.
The global Hyperimmune Globulins market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Hyperimmune Globulins by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Hepatitis B Immunoglobulins
Rabies Immunoglobulins
Tetanus Immunoglobulins
Others

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
CSL Behring
Grifols
Biotest
Kedrion
CBPO
Emergent (Cangene)
Kamada
CNBG
Hualan Bio
Shanghai RAAS
Sichuan Yuanda Shuyang
ADMA Biologics

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Government Institutions
Private Sector
Others

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)


Table of Contents
1 Industry Overview
1.1 Hyperimmune Globulins Industry
Figure Hyperimmune Globulins Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Hyperimmune Globulins
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Hyperimmune Globulins
1.2.2 Downstream
Table Application Segment of Hyperimmune Globulins
Table Global Hyperimmune Globulins Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Hyperimmune Globulins Market by Type
3.1 By Type
3.1.1 Hepatitis B Immunoglobulins
Table Major Company List of Hepatitis B Immunoglobulins
3.1.2 Rabies Immunoglobulins
Table Major Company List of Rabies Immunoglobulins
3.1.3 Tetanus Immunoglobulins
Table Major Company List of Tetanus Immunoglobulins
3.1.4 Others
Table Major Company List of Others
3.2 Market Size
Table Global Hyperimmune Globulins Market 2016-2020, by Type, in USD Million
Figure Global Hyperimmune Globulins Market Growth 2016-2020, by Type, in USD Million
Table Global Hyperimmune Globulins Market 2016-2020, by Type, in Volume
Figure Global Hyperimmune Globulins Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Hyperimmune Globulins Market Forecast 2021-2026, by Type, in USD Million
Table Global Hyperimmune Globulins Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 CSL Behring (Company Profile, Sales Data etc.)
4.1.1 CSL Behring Profile
Table CSL Behring Overview List
4.1.2 CSL Behring Products & Services
4.1.3 CSL Behring Business Operation Conditions
Table Business Operation of CSL Behring (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Grifols (Company Profile, Sales Data etc.)
4.2.1 Grifols Profile
Table Grifols Overview List
4.2.2 Grifols Products & Services
4.2.3 Grifols Business Operation Conditions
Table Business Operation of Grifols (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Biotest (Company Profile, Sales Data etc.)
4.3.1 Biotest Profile
Table Biotest Overview List
4.3.2 Biotest Products & Services
4.3.3 Biotest Business Operation Conditions
Table Business Operation of Biotest (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Kedrion (Company Profile, Sales Data etc.)
4.4.1 Kedrion Profile
Table Kedrion Overview List
4.4.2 Kedrion Products & Services
4.4.3 Kedrion Business Operation Conditions
Table Business Operation of Kedrion (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 CBPO (Company Profile, Sales Data etc.)
4.5.1 CBPO Profile
Table CBPO Overview List
4.5.2 CBPO Products & Services
4.5.3 CBPO Business Operation Conditions
Table Business Operation of CBPO (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Emergent (Cangene) (Company Profile, Sales Data etc.)
4.6.1 Emergent (Cangene) Profile
Table Emergent (Cangene) Overview List
4.6.2 Emergent (Cangene) Products & Services
4.6.3 Emergent (Cangene) Business Operation Conditions
Table Business Operation of Emergent (Cangene) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Kamada (Company Profile, Sales Data etc.)
4.7.1 Kamada Profile
Table Kamada Overview List
4.7.2 Kamada Products & Services
4.7.3 Kamada Business Operation Conditions
Table Business Operation of Kamada (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 CNBG (Company Profile, Sales Data etc.)
4.8.1 CNBG Profile
Table CNBG Overview List
4.8.2 CNBG Products & Services
4.8.3 CNBG Business Operation Conditions
Table Business Operation of CNBG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Hualan Bio (Company Profile, Sales Data etc.)
4.9.1 Hualan Bio Profile
Table Hualan Bio Overview List
4.9.2 Hualan Bio Products & Services
4.9.3 Hualan Bio Business Operation Conditions
Table Business Operation of Hualan Bio (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Shanghai RAAS (Company Profile, Sales Data etc.)
4.10.1 Shanghai RAAS Profile
Table Shanghai RAAS Overview List
4.10.2 Shanghai RAAS Products & Services
4.10.3 Shanghai RAAS Business Operation Conditions
Table Business Operation of Shanghai RAAS (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Sichuan Yuanda Shuyang (Company Profile, Sales Data etc.)
4.11.1 Sichuan Yuanda Shuyang Profile
Table Sichuan Yuanda Shuyang Overview List
4.11.2 Sichuan Yuanda Shuyang Products & Services
4.11.3 Sichuan Yuanda Shuyang Business Operation Conditions
Table Business Operation of Sichuan Yuanda Shuyang (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 ADMA Biologics (Company Profile, Sales Data etc.)
4.12.1 ADMA Biologics Profile
Table ADMA Biologics Overview List
4.12.2 ADMA Biologics Products & Services
4.12.3 ADMA Biologics Business Operation Conditions
Table Business Operation of ADMA Biologics (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Hyperimmune Globulins Sales Revenue 2016-2020, by Company, in USD Million
Table Global Hyperimmune Globulins Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Hyperimmune Globulins Sales Revenue Share in 2020, by Company, in USD Million
Table Global Hyperimmune Globulins Sales Volume 2016-2020, by Company, in Volume
Table Global Hyperimmune Globulins Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Hyperimmune Globulins Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Hyperimmune Globulins Market Concentration, in 2020
Figure Europe Hyperimmune Globulins Market Market Concentration, in 2020
Figure Asia-Pacific Hyperimmune Globulins MMarket Concentration, in 2020
Figure South America Hyperimmune Globulins Market Concentration, in 2020
Figure Middle East & Africa Hyperimmune Globulins Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Government Institutions
Figure Hyperimmune Globulins Demand in Government Institutions, 2016-2020, in USD Million
Figure Hyperimmune Globulins Demand in Government Institutions, 2016-2020, in Volume
6.1.2 Demand in Private Sector
Figure Hyperimmune Globulins Demand in Private Sector, 2016-2020, in USD Million
Figure Hyperimmune Globulins Demand in Private Sector, 2016-2020, in Volume
6.1.3 Demand in Others
Figure Hyperimmune Globulins Demand in Others, 2016-2020, in USD Million
Figure Hyperimmune Globulins Demand in Others, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Hyperimmune Globulins Demand Forecast 2021-2026, by Application, in USD Million
Figure Hyperimmune Globulins Market Growth 2021-2026, by Application, in USD Million
Figure Hyperimmune Globulins Market Share in 2026, by Application, in USD Million
Table Hyperimmune Globulins Demand Forecast 2021-2026, by Application, in Volume
Table Hyperimmune Globulins Market Growth 2021-2026, by Application, in Volume
Table Hyperimmune Globulins Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Hyperimmune Globulins Production 2016-2020, by Region, in USD Million
Table Hyperimmune Globulins Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Hyperimmune Globulins Market 2016-2020, by Region, in USD Million
Table Global Hyperimmune Globulins Market Share 2016-2020, by Region, in USD Million
Table Global Hyperimmune Globulins Market 2016-2020, by Region, in Volume
Table Global Hyperimmune Globulins Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Hyperimmune Globulins Market Size and Growth 2016-2020, in USD Million
Figure North America Hyperimmune Globulins Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Hyperimmune Globulins Market Size 2016-2020, by Country, in USD Million
Table North America Hyperimmune Globulins Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Hyperimmune Globulins Market Size and Growth 2016-2020, in USD Million
Figure Europe Hyperimmune Globulins Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Hyperimmune Globulins Market Size 2016-2020, by Country, in USD Million
Table Europe Hyperimmune Globulins Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Hyperimmune Globulins Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Hyperimmune Globulins Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Hyperimmune Globulins Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Hyperimmune Globulins Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Hyperimmune Globulins Market Size and Growth 2016-2020, in USD Million
Figure South America Hyperimmune Globulins Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Hyperimmune Globulins Market Size 2016-2020, by Country, in USD Million
Table South America Hyperimmune Globulins Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Hyperimmune Globulins Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Hyperimmune Globulins Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Hyperimmune Globulins Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Hyperimmune Globulins Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Hyperimmune Globulins Market Forecast 2021-2026, by Region, in USD Million
Table Hyperimmune Globulins Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.